REST negatively and ISGF3 positively regulate the human STAT1 gene in melanoma

Molecular Cancer Therapeutics

Volumn 12, Issue 7, 2013, Pages 1288-1298

  Amalraj, James ^a   Cutler, Samuel J ^a   Ghazawi, Ibtisam ^a   Boyle, Glen M ^b   Ralph, Stephen J ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDES AND PROTEINS; PROTEIN ISGF3; PROTEIN REST; RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; GENE; GENE EXPRESSION; MELANOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; RAT; STAT1 GENE;

EID: 84880081031     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-12-0923     Document Type: Article

References (47)

1. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD.How cells respond to interferons. Annu Rev Biochem 1998;67:227-64. (Pubitemid 28411130)
2. Stark GR, Darnell JE. The JAK-STAT pathway at twenty. Immunity 2012;36:503-14.
3. Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, et al. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 1989;58:729-39. (Pubitemid 19210966)
4. Au WC, Moore PA, Lowther W, Juang YT, Pitha PM. Identi fication of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc Natl Acad Sci U S A 1995;92: 11657-61. (Pubitemid 26014172)
5. Keller AD, Maniatis T. Identification and characterization of a novel repressor of beta-interferon gene expression. Genes Dev 1991;5:868-79. (Pubitemid 21906003)
6. Nelson N, Marks MS, Driggers PH, Ozato K. Interferon consensus sequence-binding protein, amember of the interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol Cell Biol 1993;13:588-99. (Pubitemid 23006936)
7. Bluyssen HA, Muzaffar R, Vlieststra RJ, van der Made AC, Leung S, Stark GR, et al. Combinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses. Proc Natl Acad Sci U S A 1995;92:5645-9.
8. Morrow AN, Schmeisser H, Tsuno T, Zoon KC. A novel role for IFN-stimulated gene factor 3II in IFN-γ signaling and induction of antiviral activity in human cells. J Immunol 2011;186:1685-93.
9. Lamb P, Seidel HM, Haslam J, Milocco L, Kessler LV, Stein RB, et al. STAT protein complexes activated by interferon-gamma and gp130 signaling molecules differ in their sequence preferences and transcriptional induction properties. Nucleic Acids Res 1995;23:3283-9.
10. Seidel HM, Milocco LH, Lamb P, Darnell JE, Stein RB, Rosen J. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci U S A 1995; 92:3041-5.
11. de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape JM, et al. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 2001;69:912-20. (Pubitemid 32577892)
12. Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011;331:1565-70.
13. Wong LH, Krauer KG, Hatzinisiriou I, Estcourt MJ, Hersey P, Tam ND, et al. Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma. J Biol Chem 1997;272:28779-85. (Pubitemid 27517837)
14. Abril E, Real LM, Serrano A, Jimenez P, Garcia A, Canton J, et al. Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line. Cancer Immunol Immunother 1998;47:113-20. (Pubitemid 28442710)
15. Sun WH, Pabon C, Alsayed Y, Huang PP, Jandeska S, Uddin S, et al. Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression. Blood 1998;91:570-6. (Pubitemid 28053380)
16. Pansky A, Hildebrand P, Fasler-Kan E, Baselgia L, Ketterer S, Beglinger C, et al. Defective Jak-STAT signal transduction pathway in melanoma cells resistant to growth inhibition by interferon-alpha. Int J Cancer 2000;85:720-5. (Pubitemid 30080488)
17. Kovarik J, Boudny V, Kocak I, Lauerova L, Fait V, Vagundova M. Malignant melanoma associates with deficient IFN-induced STAT 1 phosphorylation. Int J Mol Med 2003;12:335-40.
18. Ralph SJ, Wines BD, Payne MJ, Grubb D, Hatzinisiriou I, Linnane AW, et al. Resistance of melanoma cell lines to interferons correlates with reduction of IFN-induced tyrosine phosphorylation. Induction of the anti-viral state by IFN is prevented by tyrosine kinase inhibitors. J Immunol 1995;154:2248-56.
19. Boyle GM. Therapy for metastatic melanoma: an overview and update. Expert Rev Anticancer Ther 2011;11:725-37.
20. Wong LH, Sim H, Chatterjee-Kishore M, Hatzinisiriou I, Devenish RJ, Stark G, et al. Isolation and characterization of a human STAT1 gene regulatory element. Inducibility by interferon (IFN) types I and II and role of IFN regulatory factor-1. J Biol Chem 2002;277:19408-17. (Pubitemid 34967449)
21. Jia W, Zhou X. Molecular structural and functional characterization of STAT1 gene regulatory region in teleost Channa argus. Vet Immunol Immunopathol 2010;135:146-51.
22. Schoenherr CJ, Paquette AJ, Anderson DJ. Identification of potential target genes for the neuron-restrictive silencer factor. Proc Natl Acad Sci U S A 1996;93:9881-6. (Pubitemid 26296703)
23. Huang Z, Bao S. Ubiquitination and deubiquitination of REST and its roles in cancers. FEBS Lett 2012;586:1602-5.
24. Bruce AW, Donaldson IJ, Wood IC, Yerbury SA, Sadowski MI, Chapman M, et al. Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes. Proc Natl Acad Sci U S A 2004;101:10458-63. (Pubitemid 38924947)
25. Andres ME, Burger C, Peral-Rubio MJ, Battaglioli E, Anderson ME, Grimes J, et al. CoREST: a functional corepressor required for regulation of neural-specific gene expression. Proc Natl Acad Sci U S A 1999;96:9873-8. (Pubitemid 29398825)
26. Huang Y, Myers SJ, Dingledine R. Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes. Nat Neurosci 1999;2:867-72. (Pubitemid 30602598)
27. Palm K, Belluardo N, Metsis M, Timmusk T. Neuronal expression of zinc finger transcription factor REST/NRSF/XBR gene. J Neurosci 1998;18:1280-96. (Pubitemid 28082414)
28. Coulson JM, Edgson JL, Woll PJ, Quinn JP. A splice variant of the neuron-restrictive silencer factor repressor is expressed in small cell lung cancer: a potential role in derepression of neuroendocrine genes and a useful clinical marker. Cancer Res 2000;60:1840-4. (Pubitemid 30207641)
29. Shimojo M, Paquette AJ, Anderson DJ, Hersh LB. Protein kinase A regulates cholinergic gene expression in PC12 cells: REST4 silences the silencing activity of neuron-restrictive silencer factor/REST. Mol Cell Biol 1999;19:6788-95. (Pubitemid 29441862)
30. Boyle GM, Pedley J, Martyn AC, Banducci KJ, Strutton GM, Brown DA, et al. Macrophage inhibitory cytokine-1 is overexpressed in malignant melanoma and is associated with tumorigenicity. J Invest Dermatol 2009;129:383-91.
31. Martin D, Tawadros T, Meylan L, Abderrahmani A, Condorelli DF, Waeber G, et al. Critical role of the transcriptional repressor neuronrestrictive silencer factor in the specific control of connexin36 in insulin-producing cell lines. J Biol Chem 2003;278:53082-9. (Pubitemid 38035911)
32. Li Y, Liu Q, Yang Y, Lv Y, Chen L, Bai C, et al. Regulatory role of neuronrestrictive silencing factor in the specific expression of cocaine- and amphetamine-regulated transcript gene. J Neurochem 2008;106: 1314-24.
33. Strobl B, Bubic I, Bruns U, Steinborn R, Lajko R, Kolbe T, et al. Novel functions of tyrosine kinase 2 in the antiviral defense against murine cytomegalovirus. J Immunol 2005;175:4000-8. (Pubitemid 41292062)
34. Ghazawi I, Cutler SJ, Low P, Mellick AS, Ralph SJ. Inhibitory effects associated with use of modified Photinus pyralis and Renilla reniformis luciferase vectors in dual reporter assays and implications for analysis of ISGs. J Interferon Cytokine Res 2005;25:92-9102.
35. Immaneni A, Lawinger P, Zhao Z, Lu W, Rastelli L, Morris JH, et al. REST-VP16 activates multiple neuronal differentiation genes in human NT2 cells. Nucleic Acids Res 2000;28:3403-10. (Pubitemid 30662307)
36. Wong LH, Hatzinisiriou I, Devenish RJ, Ralph SJ. IFN-gamma priming up-regulates IFN-stimulated gene factor 3 (ISGF3) components, augmenting responsiveness of IFN-resistant melanoma cells to type I IFNs. J Immunol 1998;160:5475-84. (Pubitemid 28267839)
37. Sadowski HB, Shuai K, Darnell JE, Gilman MZ. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 1993;261:1739-44. (Pubitemid 23332924)
38. Lesinski GB, Trefry J, Brasdovich M, Kondadasula SV, Sackey K, Zimmerer JM, et al. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells. Clin Cancer Res 2007;13:5010-9. (Pubitemid 47502065)
39. Katsoulidis E, Mavrommatis E, Woodard J, Shields MA, Sassano A, Carayol N, et al. Role of interferon {alpha} (IFN{alpha})-inducible Schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells. J Biol Chem 2010;285: 40333-41.
40. Pine R, Canova A, Schindler C. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFN alpha and IFN gamma, and is likely to autoregulate the p91 gene. EMBO J 1994;13:158-67.
41. Cheon H, Stark GR. Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. Proc Natl Acad Sci U S A 2009;106:9373-8.
42. Gopalakrishnan V. REST and the RESTless: in stem cells and beyond. Future Neurol 2009;4:317-29.
43. Adameyko I, Lallemend F, Aquino JB, Pereira JA, Topilko P, Muller T, et al. Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin. Cell 2009;139:366-79.
44. Guardavaccaro D, Frescas D, Dorrello NV, Peschiaroli A, Multani AS, Cardozo T, et al. Control of chromosome stability by the beta-TrCP-REST-Mad2 axis. Nature 2008;452:365-9. (Pubitemid 351430786)
45. Westbrook TF, Hu G, Ang XL, Mulligan P, Pavlova NN, Liang A, et al. SCFbeta-TRCP controls oncogenic transformation and neural differentiation through REST degradation. Nature 2008;452:370-4. (Pubitemid 351430796)
46. Westbrook TF, Martin ES, Schlabach MR, Leng Y, Liang AC, Feng B, et al. A genetic screen for candidate tumor suppressors identifies REST. Cell 2005;121:837-48. (Pubitemid 40806416)
47. Otto SJ, McCorkle SR, Hover J, Conaco C, Han J-J, Impey S, et al. A new binding motif for the transcriptional repressor REST uncovers large gene networks devoted to neuronal functions. J Neurosci 2007; 27:6729-39. (Pubitemid 46983428) Scholarship